These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9760608)

  • 1. A trial of dorzolamide for glaucoma.
    Gillies WE; Brooks AM
    Ophthalmic Surg Lasers; 1998 Sep; 29(9):728-32. PubMed ID: 9760608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
    Detry-Morel M; De Hoste F
    Bull Soc Belge Ophtalmol; 1997; 267():157-66. PubMed ID: 9745826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K; Orgül S; Flammer J
    Curr Med Res Opin; 2003; 19(4):330-5. PubMed ID: 12841926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of dorzolamide-timolol combination versus the concomitant drugs.
    Choudhri S; Wand M; Shields MB
    Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol.
    Costagliola C; Campa C; Parmeggiani F; Incorvaia C; Perri P; D'Angelo S; Lamberti G; Sebastiani A
    Br J Clin Pharmacol; 2007 Mar; 63(3):376-9. PubMed ID: 16981897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.